Systematic review and exploratory meta-analysis of 7 RCTs (346 adults with treatment-resistant depression): augmenting IV ketamine with drugs or psychotherapy showed no significant benefit over control (SMD −0.12; 95% CI −0.37 to 0.12). Low-certainty evidence.
Meta-analysisn = 346
Janssen-Aguilar et al. Augmentation strategies for intravenous ketamine in treatment-resistant depression: A systematic review and meta-analysis